Tissue factor pathway inhibitors;Inhibitory zewna̧trzpochodnej drogi krzepniȩcia krwi

Polski Merkuriusz Lekarski

Volumn 13, Issue 73, 2002, Pages 66-69

  Sierko, Ewa ^a   Zawadzki, Roman J ^a   Wojtukiewicz, Marek Z ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Tissue factor (TF); Tissue factor pathway inhibitor (TFPI); Tissue factor pathway inhibitor type 2 (TFPI 2)

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; KALLIKREIN; PLACENTA PROTEIN 5; PLASMIN; TISSUE FACTOR PATHWAY INHIBITOR; TRYPSIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11A; GLYCOPROTEIN; LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR; SERINE PROTEINASE INHIBITOR; TISSUE-FACTOR-PATHWAY INHIBITOR 2;

BLOOD CLOTTING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME STRUCTURE; HEMOSTASIS; HUMAN; PROTEIN BINDING; PROTEIN SYNTHESIS; REVIEW; DRUG ANTAGONISM; METABOLISM;

ANTICOAGULANTS; BLOOD COAGULATION; FACTOR VIIA; FACTOR X; FACTOR XIA; GLYCOPROTEINS; HUMANS; KALLIKREINS; LIPOPROTEINS; PLASMIN; SERINE PROTEINASE INHIBITORS; TRYPSIN;

EID: 0036652810     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators
2. Tissue factor pathway inhibitor, potential therapeutic applications
3. Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues
4. Tissue factor pathway inhibitor
5. Tissue factor pathway inhibitor an the revised theory of coagulation
6. Full-lenght human tissue pathway inhibitor inhibits human activated protein C in the presence of heparin
7. Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. Arterioscler
8. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model
9. 24→Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2)
10. Human recombinant tissue-factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells
11. Tissue factor pathway inhibitor, its structure, function and clinical significance
12. Evidence that a second tissue factor pathway inhibitor (TFPI-2) and placental protein 5 are equivalent
13. Hemostaza fizjologiczna W: Zakrzepy i zatory (red. Łopacik S.)
14. The present status of tissue factor pathway inhibitor
15. Kinetics of the inhibition of tissue factor-tissue factor pathway inhibitor
16. Biochemistry and physiology of blood, coagulation
17. cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells, identification as placental protein 5 and tissue factor pathway inhibitor-2
18. Tissue factor pathway inhibitor
19. Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis
20. Gene expression of proteases and proteases inhibitors in the human ciliary epithelium and ODM-2 cells
21. Clearance of recombinant tissue factor pathway inhibitor in rabbits
22. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor
23. Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, 27,000) are single-gene products with differential glycosylation, cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2
24. The tissue factor pathway, how it become a "Prima Ballerina"
25. Molecular heterogeneity of placental protein 5 (PP5) in late pregnancy serum and plasma, evidence for a heparin-PP5 polymer
26. Tissue factor pathway inhibitor, clinical deficiency states
27. Hyperstimulated human preovulatory follicular fluid contains placental protein 5 (PP5)
28. Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells
29. Placental protein 5 is related to blood coagulation and fibrinolytic systems
30. Molecular cloning, expression, and partial characterization of a second tissue-factor-pathway-inhibitor
31. Specific expression of PP5/TFPI-2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization
32. Characterization of the binding between tissue factor pathway inhibitor and glycosaminoglycans
33. Distribution of tissue factor pathway inhibitor in normal and malignant human tissues
34. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin